MYO - 4 Penny Stocks To Watch In September 2020 After Big Updates
Have These Penny Stocks Made Your Watch List?
It seems like 2020 is the perfect time to start investing in penny stocks. Millions of people are sitting at home with a lot of free time to trade. But what is the best way to make money with penny stocks? Well, one of the easier ways to learn about these stocks under $5 would be through the news. Industry news can impact a company more than you might think. The main news factor moving this market recently? Well, that would be the coronavirus.
There are plenty of penny stock gainers related to developments for the coronavirus. There are also companies that will increase due to coronavirus inspired updates that are not directly related to the healthcare sector. Many companies have seen benefits from the government stimulus that has essentially put trillions of dollars into the market. So there are many reasons why a penny stock could be seeing an increased amount of volume in 2020.
[Learn More] A $3 Master Class On Profitable Day Trading Strategies?
Some tickers that used to be penny stocks have managed to escape from that segment as well. One example of this is Blue Apron Holdings Inc. (APRN Stock Report) which was at $2.50 a share in March and is now at $7.35 a share. At one point APRN stock even reached above $28 a share. There is plenty of opportunity for there to be more penny stocks on the rise. Now it’s time to see which 4 companies have made this list of penny stocks, and are performing well in September 2020.
Top Penny Stocks To Watch In September: Myomo Inc.
The first penny stock on this list is Myomo Inc. (MYO Stock Report). The company develops wearable robotics for medical use. Its offering allows for certain functionality for those suffering from neurological disorders. If MYO stock isn’t immediately familiar there’s likely a reason why. Over the last few months, with certain exceptions, the penny stock hasn’t really traded more than a few hundred thousand shares per day.
We’ve discussed in the past about how volume is important when it comes to finding top penny stocks. Considering the lack thereof, it’s no surprise that it might’ve not been on your list. However, that doesn’t mean it isn’t used to big breakouts. In fact, earlier this year, Myomo announced that Statutory Health Insurance in Germany approved MyoPro for patients on a case by case basis. German health insurer BARMER started covering the cost of the MyoPro provided through certified orthotics and prosthetics clinics in Germany
Shares shot up to highs of $40 within days. It also came right back down; within days. Needless to say, Myomo came out with more news on Tuesday that may be a source of some excitement. The Centers for Medicare & Medicaid Services under the U.S. Department of Health and Human Services has authorized the company to be a Medicare Provider. So now Myomo can bill Medicare directly in 39 states plus D.C.
Something to be completely aware of is that this is a low float penny stock. Volatility can and obviously has played a huge role in the past. If MYO is on your list of penny stocks please be completely aware that this could be a high-risk scenario depending on how the market digests this news.
Top Penny Stocks To Watch In September: Titan Pharmaceuticals Inc.
Next up on this list of penny stocks to watch is Titan Pharmaceuticals Inc. (TTNP Stock Report). Titan is a pharmaceutical company that creates therapeutics for treating chronic diseases. On September 15th, Titan announced that its Probuphine commercialization partner, Molteni, has entered an exclusive distribution deal in Europe with Accord Healthcare. This is in order to commercialize Sixmo, which is the name for Probuphine in Europe.
The CEO and President of Titan, Sunil Bhonsle said this about the partnership, “Accord is a global pharmaceutical company with a strong presence across Europe; the decision to enter the addiction treatments’ space with Sixmo confirms the attractiveness of our novel product as well as the potential of our proprietary technology to contribute to the fight against the global opioid epidemic.”
Read More
- Penny Stocks To Watch If You Like Biotech; 1 Up 287% Year To Date
- 4 Penny Stocks To Buy Under $1 Right Now; Are They Worth It?
- Top Penny Stocks To Buy, Sell Or Hold? Analysts Weigh In On These 4
The company further stated it is entitled to about $1.1 million in future milestone and royalty payments on the net sales of Sixmo, which begins in 2021. This has triggered momentum for TTNP stock this week. The penny stock jumped from around $0.19 a share to $0.2344 a share at the high on Tuesday.
Top Penny Stocks To Watch In September: R. R. Donnelley & Sons Company
In other penny stock news, let’s talk about R. R. Donnelley & Sons Company (RRD Stock Report). This company is a communications provider that allows organizations to make, manage, deliver, and optimize multichannel marketing and business communications. Its business segment allows for commercial printing products and branded materials. RRD announced that it entered a definitive agreement to sell its DLS Worldwide Logistics company to TFI International for $225 million. This deal will be executed in cash.
Dan Knotts, the President and CEO of RRD said this about the sale: “The sale of our DLS Worldwide business further demonstrates our strategic focus and ongoing commitment to optimize our business portfolio, reduce debt and improve liquidity.”
RRD said it believes this will allow it to continue as a strongly positioned industry leader of its market. Before the sale, RRD stock price was $1.18 a share. Tuesday saw RRD stock jumped 25% to highs of $1.48. It will be interesting to see how this penny stock evolves in the coming week following such a surge on September 15th.
Top Penny Stocks To Watch In September: Oragenics Inc.
The last company on this list of penny stocks to watch is Oragenics Inc. (OGEN Stock Report). It’s a healthcare company that develops novel antibiotics that attack infectious diseases and treatments for oral mucositis. It is actively developing an antibiotic product called OG716. The company is also developing AG013 which is in Phase II for treating oral mucositis in cancer patients. Currently, Oragenics is focused on creating Terra CoV-2, its vaccine candidate for the coronavirus.
[Read More] 4 Robinhood Penny Stocks To Watch This Week
There is some hype around OGEN stock at the moment. Oragenics plans on presenting at the H.C. Wainwright 22nd Annual Global investment conference this week. This is where the CEO and President Alan Joslyn could provide some important updates for Oragenics progress on not only Terra CoV-2, but its other treatments as well.
The week of September 14th, OGEN stock is up 15% to $0.75 a share as of Tuesday’s close. The upcoming conference could be something to keep in mind heading into the rest of the week.